Resultados de la búsqueda 321-330 of 3360 for GLP-1 therapy
The primary goal of the registry is characterizing patterns of use for NSCLC therapy. REVOLUTION will be a multicenter registry enrolling approximately 2,500 ...
... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 ... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy ...
The purpose of this study is to investigate whether VNS therapy leads to any changes in the cognitive functions of individuals who have survived a stroke. A ...
... one parent is known by prior genetic testing to have a mutation in one of the common LQTS genes: potassium voltage-gated channel subfamily Q member 1 (KCNQ1) ...
Actinium Therapy For Late-stage Aggressive Sarcomas ... The main questions the study aims to answer in Phase/Part 1 of the trial are: ... 1 for check-ups and tests.
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and ...
Other genes can increase the risk of getting certain diseases, including AATD. One gene tells the liver to make alpha-1-antitrypsin (AAT or A1AT) protein. This ...
... treatment monitoring in patients with metastatic breast cancer. ... treatment success. Gemini Study ... Ir a página 11 · Ir a página 22 · Ir a página 33 · Ir a ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?